🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open-label, randomized, comparative phase II study including patients wi...
Status
Recruiting
Location
Chinese PLA General Hospital, Beijing
Start Date
2025-08-06
Trial ID
NCT07103668
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of IMC-002...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2024-10-10
Trial ID
NCT06535412
Treatments Being Tested
This is an Open-Label, Dose-Escalation and Expansion, Phase I Study to Inve...
Status
Recruiting
Location
National Cancer Center
Start Date
2022-06-02
Trial ID
NCT05276310
Treatments Being Tested
This is the first-in-human, Phase I, open-label, multiple-ascending dose st...
Status
Completed
Location
Washington University School of Medicine - Siteman Cancer Center
Start Date
2020-06-05
Trial ID
NCT04306224
Treatments Being Tested
This is an open-label, multi-center, dose-escalation clinical study to eval...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2023-09-07
Trial ID
NCT05946226
Treatments Being Tested
This is an open label, multi-center, Phase 1 clinical trial to evaluate the...
Status
Unknown
Location
Changhai Hospital
Start Date
2022-08-08
Trial ID
NCT05472857
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of IMC-002...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-10
Trial ID
NCT06557174
Treatments Being Tested